- Personalized Medicine in 2012: Industry Takes a Wait-and-See Approach Due to Market Unknowns
January 9, 2013 / Pharmacogenomics Reporter
- With Decode Purchase, Amgen Gains Genetics Expertise, Consumers Lose DTC Testing Option
December 12, 2012 / Pharmacogenomics Reporter
- Life Tech Relies on Partners, Acquisitions to Develop Personalized Rx Decision Support Tool for Docs
October 10, 2012 / Pharmacogenomics Reporter
- Life Tech to Market Dx Version of QuantStudio Platform; Developing Assays with Quidel
July 26, 2012 / PCR Insider
- Following CLIA Lab Buy, Life Tech Jumps into MDx Space with Purchase of Pinpoint, Lung Cancer Dx
July 25, 2012 / Pharmacogenomics Reporter